Absolute Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$435K Buy
375
+135
+56% +$159K 0.1% 125
2026
Q2
$288K Sell
240
-13
-5% -$13.3K 0.07% 142
2026
Q1
$233K Buy
253
+8
+3% +$8.11K 0.08% 137
2025
Q4
$263K Buy
+245
New +$234K 0.1% 114
2025
Q1
– Sell
-307
Closed -$238K – 124
2024
Q4
$238K Buy
307
+31
+11% +$25.7K 0.13% 113
2024
Q3
$245K Sell
276
-5
-2% -$4.5K 0.15% 102
2024
Q2
$254K Buy
+281
New +$225K 0.15% 96
2022
Q4
– Sell
-72
Closed -$23.6K – 333
2022
Q3
$23.6K Buy
+72
New +$22.8K 0.03% 120
2022
Q1
– Sell
-2
Closed -$552 – 306
2021
Q4
$552 Buy
+2
New +$507 ﹤0.01% 491

Other funds holding LLY

Absolute Capital Management's LLY Position: Q3 2026 in Review

Absolute Capital Management increased its Eli Lilly (LLY) stake by 56% in Q3 2026, buying an estimated $159K and bringing the position to 375 shares worth $435K. The position accounts for 0.1% of the portfolio, ranked #125.

Absolute Capital Management first reported a position in LLY in Q4 2021 and has held it in 9 quarters since. 1,995 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Absolute Capital Management held 375 shares of Eli Lilly worth $435K as of Q3 2026.
  • Absolute Capital Management bought 135 Eli Lilly shares in Q3 2026, an estimated $159K.
  • Eli Lilly made up 0.1% of Absolute Capital Management's portfolio in Q3 2026, its #125 holding.
  • Absolute Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 9 quarters since.
  • 1,995 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Absolute Capital Management's 13F filing for Q3 2026, filed 16 Oct 2026.